Delivery Order SPE2DB20D3103-SPE2DB25FQ2T2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units, with a ceiling value of $12,332.70 and firm fixed pricing. This non-set-aside competitive delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Azithromycin 500 mg tablets (30-count packaging) with a ceiling value of $9,828.00. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set to be completed by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units, with a contract ceiling value of $2,603.50. This delivery order represents a firm fixed-price procurement with an ultimate completion date of August 21, 2025, and was competitively awarded without set-aside provisions. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $16,453.75 and an ultimate completion date of July 25, 2025. The contract was competitively awarded with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Azithromycin 500 mg tablets in a quantity of 30 units, with a ceiling value of $2,615.32. This contract utilizes a firm fixed price structure and represents a non-set-aside competitive award. The delivery order is scheduled for ultimate completion by July 21, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $4,486.90 and a completion date of August 1, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units, with a ceiling value of $6,311.42. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on capability. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets in quantities of 30 units, with a ceiling value of $16,675.20. This contract, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units. This contract, valued at $6,100.26, represents a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The award is non-competitive and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units under a firm fixed-price contract valued at $4,548.82. The contract is not set-aside and represents a competitive award to the pharmaceutical distributor for delivery to its facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery order is issued under...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ2T2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $12,332.70 and an ultimate completion date of September 15, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The award reflects the company's established capability to meet federal pharmaceutical procurement requirements through competitive processes and its role as a key vendor within the DLA's broader pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 9/12/25 |